Special because of Goldman Philanthropic Partnerships for funding this sequence.
00:00 – Introduction to Second-Line Hodgkin Lymphoma Therapy
01:24 – Three-Step Treatment Strategy
02:21 – Salvage Chemotherapy and Targeted Drugs
03:09 – Autologous Stem Cell Transplant Explained
04:09 – Consolidation Treatment for High-Risk Patients
05:39 – Options for Stubborn or Relapsed Disease
06:45 – Conclusion and Key Takeaways
07:15 – Acknowledgments
Descriptions:
00:00 – Introduction to Second-Line Hodgkin Lymphoma Therapy
Introduction to Dr. Steve Ansell, a hematologist at Mayo Clinic and the subject of second-line and subsequent remedy choices for sufferers with Hodgkin lymphoma.
01:24 – Three-Step Treatment Strategy
This part outlines the final rules of second-line remedy, that are damaged down into three fundamental phases, salvage remedy to scale back the most cancers to a low degree, an autologous stem cell transplant to accentuate remedy and additional eradicate most cancers cells, consolidation remedy to take care of the profit and stop relapse in high-risk sufferers, and a fourth class of further choices for sufferers who relapse once more.
02:21 – Salvage Chemotherapy and Targeted Drugs
Salvage chemotherapy makes use of completely different medication than these within the frontline remedy. This remedy is usually mixed with novel, focused medication resembling brentuximab vedotin (targets CD30) or nivolumab and pembrolizumab (goal PD-1 and activate the immune system). The objective is to shrink the most cancers and get it below management earlier than the subsequent step.
03:09 – Autologous Stem Cell Transplant Explained
Process of an autologous stem cell transplant. "Autologous" means the affected person’s personal bone marrow is used. Stem cells are collected and frozen. The affected person then receives high-dose chemotherapy to kill the remaining most cancers cells, and the saved stem cells are re-infused to regenerate the bone marrow. This intensive remedy is a key step in pursuing a remedy.
04:09 – Consolidation Treatment for High-Risk Patients
For sufferers at excessive threat of relapse (e.g., those that had a poor response to preliminary remedy or whose most cancers returned shortly). This usually includes utilizing medication like brentuximab vedotin or radiation remedy to cumbersome tumor areas to take care of the remedy’s advantages and cut back the possibility of the most cancers coming again.
05:39 – Options for Stubborn or Relapsed Disease
Treatment choices for the uncommon instances the place the most cancers returns even after intensive therapies like a stem cell transplant. These choices embrace PD-1 blocking antibodies (pembrolizumab or nivolumab), different immune checkpoint inhibitors, and newer therapies being examined in scientific trials, resembling CAR-T cells or bispecific antibodies.
06:45 – Conclusion and Key Takeaways
Reinforcing that a number of efficient therapies exist for Hodgkin lymphoma and that the last word objective, even in second-line remedy, is a remedy.
07:15 – Acknowledgments
The video ends with acknowledgements to the sufferers, the Mayo Clinic Lymphoma Disease-Oriented Group, and the Goldman Philanthropic Partnerships for his or her donation that funded the academic sequence.
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
